Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,1 USD | -2,26% | -8,08% | +104,04% |
Omzet 2024 * | 68,09 mln. 63,1 mln. | Omzet 2025 * | 86,75 mln. 80,39 mln. | Marktkapitalisatie | 1,35 mld. 1,25 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -87 mln. -80,62 mln. | Nettowinst (verlies) 2025 * | -91 mln. -84,33 mln. | EV/omzet 2024 * | 19,9 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 15,6 x |
K/w-verhouding 2024 * |
-13,5
x | K/w-verhouding 2025 * |
-12,6
x | Werknemers | 267 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,32% |
Recentste transcriptie over Ocular Therapeutix, Inc.
1 dag | -2,26% | ||
1 week | -8,08% | ||
Lopende maand | -9,54% | ||
1 maand | -8,08% | ||
3 maanden | +102,22% | ||
6 maanden | +186,16% | ||
Lopend jaar | +104,04% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-06-17 | |
Donald Notman
DFI | Director of Finance/CFO | 64 | 25-09-17 |
Chief Tech/Sci/R&D Officer | - | 28-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adrienne Graves
BRD | Director/Board Member | 69 | 10-07-23 |
Director/Board Member | 76 | 05-11-12 | |
Merilee Raines
BRD | Director/Board Member | 68 | 20-09-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 8 M€ | +9,75% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 9,1 | -2,26% | 2 198 973 |
27-03-24 | 9,31 | +1,20% | 1 067 466 |
26-03-24 | 9,2 | -2,23% | 1 392 487 |
25-03-24 | 9,41 | -0,84% | 936 320 |
22-03-24 | 9,49 | -6,50% | 1 417 937 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+104,04% | 1,38 mld. | |
+33,46% | 701 mld. | |
+26,24% | 571 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 319 mld. | |
+0,74% | 210 mld. | |
+2,95% | 210 mld. | |
-6,05% | 201 mld. | |
-3,61% | 157 mld. |